HeLa Apoptosis Lysate Set: Staurosporine-Treated and Vehicle-Treated Control (ab136806)
Overview
-
Product name
HeLa Apoptosis Lysate Set: Staurosporine-Treated and Vehicle-Treated Control -
Product overview
Staurosporine is a broad-spectrum inhibitor of serine/threonine kinases and tyrosine kinases. It is commonly used to induce apoptosis in experimental settings, although the mechanism is not fully understood.
The staurosporine-treated HeLa lysate is designed for use as a western blot positive control for antibodies against apoptosis-specific proteins or for experimental treatments to induce apoptosis. -
Notes
Confluent HeLa cells were treated with either the vehicle (DMSO, 0.2%) or staurosporine (1 uM) for 4 hours. Cells were pelleted then lysed with Lysis Buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM NaF, 1x Protease Inhibitors, 1% SDS) and the lysate cleared by sonication. The protein concentration was measured by BCA assay. Modified 5x SDS sample buffer was added to the lysate before storage at -80ºC. The lysates were validated by western blotting with the ab136812 Apoptosis WB cocktail (cleaved PARP, actin, caspase 3).
-
Tested applications
Suitable for: WB, SDS-PAGEmore details
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 2 units Staurosporine-Treated HeLa Lysate 1 x 200µg Control for Staurosporine-Treated Lysate 1 x 200µg -
Research areas
Images
-
Western BlotLane 1: HeLa, vehicle (DMSO) treated for 4 hours Lane 2: HeLa 1 µM staurpsorine, 4 hours Load 20 µg/lane 5% milk/PBST for block and antibody diluent Primary antibodies (2 hours, room temp) All lanes: ab136812 250X Primary Antibodies Cocktail, 1/250 dilution Secondary antibodies (1 hour, room temp) All lanes: ab136812 100X HRP-Conjugated Secondary Antibodies Cocktail, 1/100 dilution
